PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER

Clinical trials for PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER explained in plain language.

Never miss a new study

Get alerted when new PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER trials appear

Sign up with your email to follow new studies for PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test two new drug cocktails in battle against deadly pancreatic cancer

Disease control Ongoing

This study is testing two new combinations of chemotherapy drugs for people with advanced pancreatic cancer that has spread. Researchers want to see if adding either of two different drugs to standard treatment can help control the cancer for longer. The trial will compare which …

Matched conditions: PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER

Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER

Get alerted when new PHASE II, OPEN-LABEL, PARALLEL 2-ARM, MULTI-CENTER trials appear

Scientists test two new drug cocktails in battle against deadly pancreatic cancer